JP2021008481A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021008481A5 JP2021008481A5 JP2020164124A JP2020164124A JP2021008481A5 JP 2021008481 A5 JP2021008481 A5 JP 2021008481A5 JP 2020164124 A JP2020164124 A JP 2020164124A JP 2020164124 A JP2020164124 A JP 2020164124A JP 2021008481 A5 JP2021008481 A5 JP 2021008481A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- medicament according
- tumor
- time
- gitrl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022112196A JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562101850P | 2015-01-09 | 2015-01-09 | |
| US62/101,850 | 2015-01-09 | ||
| US201562126300P | 2015-02-27 | 2015-02-27 | |
| US62/126,300 | 2015-02-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536882A Division JP2018504403A (ja) | 2015-01-09 | 2016-01-08 | 悪性腫瘍の治療に対する方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022112196A Division JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021008481A JP2021008481A (ja) | 2021-01-28 |
| JP2021008481A5 true JP2021008481A5 (https=) | 2021-05-06 |
| JP7111384B2 JP7111384B2 (ja) | 2022-08-02 |
Family
ID=56356515
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536882A Pending JP2018504403A (ja) | 2015-01-09 | 2016-01-08 | 悪性腫瘍の治療に対する方法 |
| JP2020164124A Active JP7111384B2 (ja) | 2015-01-09 | 2020-09-29 | 悪性腫瘍の治療に対する方法 |
| JP2022112196A Pending JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017536882A Pending JP2018504403A (ja) | 2015-01-09 | 2016-01-08 | 悪性腫瘍の治療に対する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022112196A Pending JP2022137203A (ja) | 2015-01-09 | 2022-07-13 | 悪性腫瘍の治療に対する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20180000895A1 (https=) |
| EP (2) | EP3242947B1 (https=) |
| JP (3) | JP2018504403A (https=) |
| CA (1) | CA2973390A1 (https=) |
| DK (1) | DK3242947T3 (https=) |
| ES (1) | ES2809734T3 (https=) |
| MX (1) | MX383277B (https=) |
| PL (1) | PL3242947T3 (https=) |
| WO (1) | WO2016112359A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3242947T3 (pl) * | 2015-01-09 | 2021-01-11 | Oncosec Medical Incorporated | Terapia genowa i elektroporacja do leczenia zmian złośliwych |
| JP7287888B2 (ja) | 2016-06-27 | 2023-06-06 | ギャラリー，インコーポレイテッド | ジェネレータ、電極付きのカテーテル、及び肺通路の治療方法 |
| US12403305B2 (en) | 2016-06-27 | 2025-09-02 | Galvanize Therapeutics, Inc. | Immunostimulation in the treatment of viral infection |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| DK4218641T3 (da) | 2017-12-26 | 2025-08-18 | Galvanize Therapeutics Inc | Optimering af energilevering til forskellige anvendelser |
| AU2019263465A1 (en) * | 2018-05-02 | 2020-12-24 | Grand Decade Developments Limited | Electroporation systems, methods, and apparatus |
| KR102753455B1 (ko) * | 2018-08-08 | 2025-01-10 | 세다르스-신나이 메디칼 센터 | 암 및 자가면역 질환을 치료하기 위한 조성물 및 방법 |
| JP7551648B2 (ja) | 2019-04-18 | 2024-09-17 | ガルヴァナイズ セラピューティクス，インコーポレイテッド | 異常組織を治療するための器械、及びシステム、 |
| AU2020314830B2 (en) | 2019-07-16 | 2026-01-22 | Galvanize Therapeutics, Inc. | Treatment of the reproductive tract with pulsed electric fields |
| KR20220061977A (ko) | 2019-08-12 | 2022-05-13 | 퓨리노미아 바이오테크, 아이엔씨. | Cd39 발현 세포의 adcc 표적화를 통해 t 세포 매개 면역 반응을 촉진 및 강화하기 위한 방법 및 조성물 |
| WO2021074695A1 (en) | 2019-10-16 | 2021-04-22 | Avacta Life Sciences Limited | PD-L1 INHIBITOR - TGFβ INHIBITOR BISPECIFIC DRUG MOIETIES. |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| TW202332694A (zh) | 2021-10-07 | 2023-08-16 | 英商阿凡克塔生命科學公司 | 血清半衰期延長之ｐｄ－ｌ１結合多肽 |
| TW202334196A (zh) | 2021-10-07 | 2023-09-01 | 英商阿法克塔生命科學有限公司 | Pd-l1結合多肽 |
| WO2023153876A1 (ko) | 2022-02-10 | 2023-08-17 | 주식회사 아피셀테라퓨틱스 | Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도 |
| JP2025515486A (ja) | 2022-04-29 | 2025-05-15 | ピュリノミア バイオテック， インコーポレイテッド | 好酸球駆動性疾患及び障害を治療するための方法及び組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5993434A (en) * | 1993-04-01 | 1999-11-30 | Genetronics, Inc. | Method of treatment using electroporation mediated delivery of drugs and genes |
| US20030049696A1 (en) | 2001-06-07 | 2003-03-13 | Norment Anne M. | Regulatory T cells and uses thereof |
| US7245963B2 (en) | 2002-03-07 | 2007-07-17 | Advisys, Inc. | Electrode assembly for constant-current electroporation and use |
| US8209006B2 (en) | 2002-03-07 | 2012-06-26 | Vgx Pharmaceuticals, Inc. | Constant current electroporation device and methods of use |
| US20110142887A1 (en) * | 2009-12-15 | 2011-06-16 | Immunovative Therapies Ltd. | Methods and compositions for liquidation of tumors |
| AU2004247071B2 (en) | 2003-05-30 | 2010-03-11 | University Of South Florida | Method for the treatment of malignancies |
| US8802643B1 (en) | 2003-05-30 | 2014-08-12 | University Of South Florida | Method for the treatment of malignancies |
| US7923251B2 (en) | 2005-02-23 | 2011-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for avalanche-mediated transfer of agents into cells |
| US8101169B2 (en) | 2005-02-23 | 2012-01-24 | The Board Of Trustees Of The Leland Stanford Junior University | Ocular gene therapy using avalanche-mediated transfection |
| CA2636424A1 (en) * | 2006-01-09 | 2007-10-25 | The Regents Of The University Of California | Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy |
| JPWO2010030002A1 (ja) * | 2008-09-12 | 2012-02-02 | 国立大学法人三重大学 | 外来性ｇｉｔｒリガンド発現細胞 |
| KR102277469B1 (ko) * | 2011-12-12 | 2021-07-15 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 개선된 il-12 유전적 컨스트럭트 및 백신을 포함하는 조성물, 면역치료제 및 이를 이용하는 방법 |
| PL3242947T3 (pl) * | 2015-01-09 | 2021-01-11 | Oncosec Medical Incorporated | Terapia genowa i elektroporacja do leczenia zmian złośliwych |
-
2016
- 2016-01-08 PL PL16735524T patent/PL3242947T3/pl unknown
- 2016-01-08 EP EP16735524.7A patent/EP3242947B1/en active Active
- 2016-01-08 WO PCT/US2016/012759 patent/WO2016112359A1/en not_active Ceased
- 2016-01-08 CA CA2973390A patent/CA2973390A1/en active Pending
- 2016-01-08 JP JP2017536882A patent/JP2018504403A/ja active Pending
- 2016-01-08 US US15/542,415 patent/US20180000895A1/en not_active Abandoned
- 2016-01-08 ES ES16735524T patent/ES2809734T3/es active Active
- 2016-01-08 DK DK16735524.7T patent/DK3242947T3/da active
- 2016-01-08 EP EP20176001.4A patent/EP3799879B1/en active Active
- 2016-01-08 MX MX2017009044A patent/MX383277B/es unknown
-
2020
- 2020-09-29 JP JP2020164124A patent/JP7111384B2/ja active Active
-
2022
- 2022-07-13 JP JP2022112196A patent/JP2022137203A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021008481A5 (https=) | ||
| Mir | Bases and rationale of the electrochemotherapy | |
| Panje et al. | Electroporation therapy of head and neck cancer | |
| Cadossi et al. | Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy | |
| Liebetanz et al. | Anticonvulsant effects of transcranial direct‐current stimulation (tDCS) in the rat cortical ramp model of focal epilepsy | |
| AU2007224275B2 (en) | Method and device for treating microscopic residual tumors remaining in tissues following surgical resection | |
| CN118948428A (zh) | 用于选择性细胞消融的时间多路复用波形 | |
| P Spugnini et al. | Electrochemotherapy as first line cancer treatment: experiences from veterinary medicine in developing novel protocols | |
| CN116867544A (zh) | 通过在少于一半的时间在峰值强度处施加肿瘤治疗场（TTField）来增加TTField的功效 | |
| Fregni et al. | Effects of transcranial direct current stimulation coupled with repetitive electrical stimulation on cortical spreading depression | |
| US20120283502A1 (en) | Ultrasound neuromodulation treatment of depression and bipolar disorder | |
| Hofmann et al. | Electroporation therapy of solid tumors | |
| Burnette et al. | The immunology of ablative radiation | |
| Vlaicu et al. | New neuromodulation techniques for treatment resistant depression | |
| NO922441D0 (no) | Fremgangsmaate og apparat for pulset, iontoforetisk avgivelse av medikamenter | |
| Cha et al. | Plasmid IL-12 electroporation in melanoma | |
| Yanagisawa et al. | Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75) | |
| JP7815261B2 (ja) | 複合神経調節技法 | |
| US11931569B2 (en) | Method for changing blood brain barrier permeability | |
| CN107185107A (zh) | 一种超声直流电离子导入系统 | |
| Giannola et al. | Physical methods to promote drug delivery on mucosal tissues of the oral cavity | |
| Spinks et al. | Problem of dural scarring in recording from awake, behaving monkeys: a solution using 5-fluorouracil | |
| CN113710311A (zh) | 神经刺激系统 | |
| Baranski et al. | Studies on the combined effects of microwaves and some drugs on bioelectric activity of the rabbit central nervous system | |
| Cemazar et al. | 24 Electroporation for Electrochemotherapy and Gene Therapy |